Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Lung Neoplasms 9Carcinoma 3Carcinoma, Squamous Cell 2Carcinoma, Large Cell 2Adenocarcinoma 2ALK-positive Advanced NSCLC 2Sexual Dysfunction, Physiological 1Neoplasms 1NSCLC 1Lymphoma, Large-Cell, Anaplastic 1Gastrointestinal Neoplasms 1Eunuchism 1Erectile Dysfunction 1Disease Progression 1Breast Neoplasms 1Brain Neoplasms 1ALK-positive NSCLC 1ALK+ Advanced NSCLC 1

Interventions

Radiosurgery 27Radiotherapy 17Magnetic Resonance Spectroscopy 14Erlotinib Hydrochloride 14Bevacizumab 13Pemetrexed 10Carboplatin 10pembrolizumab 9Gefitinib 9osimertinib 8icotinib 7Temozolomide 7Nivolumab 6Specimen Handling 5Paclitaxel 5Spermine Synthase 4Mental Status and Dementia Tests 4Ipilimumab 4Drug Therapy 4Cisplatin 4atezolizumab 3alectinib 3aflutinib 3Radiation 3Immunotherapy 3Fluorodeoxyglucose F18 3regorafenib 2paclitaxel-Angiopep-2 conjugate 2motexafin gadolinium 2epothilone B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × brigatinib × Thoracic × Clear all
NCT04634110 2022-10-24

Brigatinib Before Brain Irradiation Trial (B3i Trial)

University of Colorado, Denver

Phase 2 Terminated
1 enrolled 6 charts
CNSThoracic

Brain Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡